Erytech Pharma SA (NASDAQ: ERYP) Reports Net loss of €11.9 Million in the First Quarter of 2021

July 7, 2021

Erytech Pharma SA (NASDAQ: ERYP) reported a Net loss of €11.9 million in the first quarter of 2021. The loss is depressed €5.6 million -32% year-over-year, with a €5.8 million reduction -31% in operating loss and a €0.2 million reduction in financial proceeds. The €5.8 million reductions in the operating loss were attributable to the €4.8 million reductions in preclinical and clinical development expenditures. The company has cash and cash…

Read More >>